谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Randomised, Parallel-Group, Double-Blind, Placebo-Controlled Phase 3 Study to Determine the Effectiveness of the Type I Interferon Receptor Antibody, Anifrolumab, in SYstemic Sclerosis: DAISY Study Design and Rationale

D. Khanna,C. P. Denton,S. Assassi,M. Kuwana,Y. Allanore,R. T. Domsic,C. Kleoudis,J. Xu,E. Csomor,C. Seo,M. Albulescu,R. Tummala,H. Al-Mossawi,R. N. Kalyani,F. Del Galdo

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY（2024）

引用 0|浏览0
暂无评分
关键词
autoimmune disease,systemic sclerosis,anifrolumab,type I interferon
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要